Search Results 351-360 of 14944 for alt

  1. Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer - Mayo Clinic

    Note: If alanine aminotransferase (ALT) is performed instead of AST (per institution's standard practice), the ALT value must be less than or equal to 1.5 x ...

  2. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

    Leukocytes ≥3,000/mcL Absolute neutrophil count ≥1,500/mcL Platelets ≥100,000/mcL Total bilirubin ≤ 2.5 x limit of normal (ULN) AST(SGOT)/ALT(SGPT) ≤5 ...

  3. A Study To Assess The Safety And Tolerability Of CFT7455 In Relapsed/Refractory Non-Hodgkin's Lymphoma Or Multiple Myeloma - Mayo Clinic

    - ALT and AST ≤3.0 x upper limit of normal (ULN); except for subjects who have tumor infiltration of the liver, where ALT or AST ≤5 x ULN. - Total ...

  4. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

    AST (SGOT) or ALT (SGPT) < 3 x institutional ULN. Ability to complete questionnaire(s) by themselves or with assistance. Able to provide written informed ...

  5. Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis - Mayo Clinic

    AST and ALT ≤ 5 × upper limit of normal (ULN). Exclusion Criteria: Hepatitis B surface Antigen (HBsAg) positive; Hepatitis C antibody (HCVAb) positive with ...

  6. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

    ... ALT ≤ 3 x upper institutional limit of normal;; Serum total bilirubin < 1.5 mg/dL with the following exception: patients with known Gilbert's disease, serum ...

  7. Metabolic dysfunction-Associated Fatty Liver Disease - Mayo Clinic

    FIB-4 score ≥ 2.67 (calculated from patient's age, AST, ALT, and platelet count); AST ≥ 30. Exclusion Criteria: Comorbidities that limit life expectancy to ...

  8. Mechanisms of Anabolic Resistance in Older Humans - Mayo Clinic

    Chronic active liver disease (AST > 144IU/L or ALT > 165IU/L); Oral warfarin group medications or history of blood clotting disorders. Smoking. Pregnancy or ...

  9. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Aspartate aminotransferase (AST), alanine aminotransferase (ALT) =< 3 x upper limit of normal (ULN), unless suspected leukemic involvement of the liver.

  10. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

    Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN; Albumin ≥ 2.8 g/dL; Serum creatinine ≤ 1.5 x ULN, OR calculated creatinine ...